about
CRISPR-Mediated Epigenome EditingOxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyRegulation and involvement of matrix metalloproteinases in vascular diseasesEffects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cellsEpigenetics in kidney development and renal diseaseObservation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathyRecent developments in epigenetics of acute and chronic kidney diseases.Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.Epigenetic Regulation of Werner Syndrome Gene in Age-Related Cataract.Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice.Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathyThe Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Origins and consequences of hyperosmolar stress in retinal pigmented epithelial cells.Epigenetic modifications and potential new treatment targets in diabetic retinopathyRole of mtDNA-related mitoepigenetic phenomena in cancer.Contribution of epigenetics in diabetic retinopathy.The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.Diabetic retinopathy: Breaking the barrier.Polymorphisms in the CTSH gene may influence the progression of diabetic retinopathy: a candidate-gene study in the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).CAPE increases the expression of SOD3 through epigenetics in human retinal endothelial cells.Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiologyEmerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.Global DNA methylation as a possible biomarker for diabetic retinopathy.Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model.Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes.Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration.The genetics of retinopathy of prematurity: a model for neovascular retinal diseaseDeep Learning in Drug Discovery and Medicine; Scratching the Surface
P2860
Q28075872-19249F06-85BF-4194-B265-6DB8B2D64246Q29248994-0CC674B5-D1DC-4BA3-8426-60A464700BC4Q33773304-EADEEA0D-FD9F-4D7C-B857-C88302DC08A5Q34249929-E7761DE4-4C49-48C5-A074-BB8FDB6C1EBFQ34633331-B2F28A39-AE0F-448F-BE7B-2699E26A0A56Q35110403-36B2FB81-84F0-4729-A371-AAC0E893AB41Q35608796-C6B6960E-33E4-4C24-A133-98E56FEF06F7Q35909055-9C6C61B4-84FE-4C46-8C60-DED828CB3B8CQ35918468-D207E604-D75A-43E0-9F64-D7A4820BB49AQ36088748-58D79591-F8F1-4B22-B920-29B42743A18FQ36174307-C35588F4-0370-4437-960F-6C3F0DD2E64DQ36784339-D40170A6-44DD-4806-AA40-1025E1075C75Q36961035-DE91F73C-BA1D-47F3-B9A6-A68D18F0EFCAQ37247435-11A0C9A9-CD54-4C7A-99D6-75229BF7163CQ37280210-61877282-11F2-449B-84AB-5CFA69ECB499Q37384357-C21BBDAC-6773-479D-9E13-63CFC074B853Q38218669-06D608C2-9967-4EE3-9751-F34E63E0DE94Q38244141-81897D96-82BE-4CC5-8E39-525B7DB179C7Q38294209-2138C5DC-2E39-4718-999A-769F4B8FBF3BQ38508141-07F4B3A2-C202-41D1-84F2-1C066D52C3BBQ38710512-2CBB9186-956E-4010-93FB-C64BFFD32F14Q39451009-6BD66F27-22CB-469E-8E1A-0B29DA187379Q40657532-9CE6BC74-33A4-49EB-8DD6-7A18E684481AQ41109983-E0239AF4-054E-4862-A7D6-42AE093221A2Q41374334-C990D4F5-EC59-4421-B948-6A13C9D953BDQ47159412-834C3172-D1F6-4861-81CC-E40CBA70DBC1Q50790138-BD3A7DE7-1538-4735-A9DE-61741AB91451Q50931649-B96BBD79-FBF9-4503-A856-0EB6A5C3AEC0Q50948454-61A7C175-AE9A-4A89-8174-0C14D091DD8AQ51026956-332BCE79-F119-4106-B504-81ED25126FF4Q53699893-28A4FF69-8B09-4D39-8022-3BFC5CC1B86CQ57165717-043CDEDC-E14C-4987-8896-272BA8EE6783Q58691544-7AC67090-5150-4208-8C75-2AD3FBFBAACA
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Epigenetic modifications and diabetic retinopathy
@ast
Epigenetic modifications and diabetic retinopathy
@en
Epigenetic modifications and diabetic retinopathy
@en-gb
Epigenetic modifications and diabetic retinopathy
@nl
type
label
Epigenetic modifications and diabetic retinopathy
@ast
Epigenetic modifications and diabetic retinopathy
@en
Epigenetic modifications and diabetic retinopathy
@en-gb
Epigenetic modifications and diabetic retinopathy
@nl
altLabel
Epigenetic Modifications and Diabetic Retinopathy
@en
prefLabel
Epigenetic modifications and diabetic retinopathy
@ast
Epigenetic modifications and diabetic retinopathy
@en
Epigenetic modifications and diabetic retinopathy
@en-gb
Epigenetic modifications and diabetic retinopathy
@nl
P2860
P3181
P356
P1476
Epigenetic modifications and diabetic retinopathy
@en
P2093
Manish Mishra
Renu A Kowluru
P2860
P304
P3181
P356
10.1155/2013/635284
P407
P50
P5008
P577
2013-10-28T00:00:00Z